Kits for detecting mycobacterium avium/intracellulare nucleic acid

• US 9,797,018 B2
• Filed: 11/14/2011
• Issued: 10/24/2017
• Est. Priority Date: 01/23/2006
• Status: Active Grant

• Current Assignee: Quest Diagnostics Investments Incorporated (Quest Diagnostics Incorporated)
• Original Assignee: Quest Diagnostics Investments Incorporated (Quest Diagnostics Incorporated)
• Inventors: Ong, Edgar, Exner, Maurice
• Primary Examiner(s): Johannsen, Diana B
• Application Number:
  US13/296,046
• Publication Number:
  US 20120088242A1
• Time in Patent Office: 2,171 Days
• Field of Search: None
• CPC Class Codes: C12Q 1/689 for bacteria
• CPC Class Codes: C12Q 2600/16 Primer sets for multiplex assays

Abstract

Disclosed is a method for determining the presence of Mycobacterium avium complex nucleic acids in a biological sample. In particular, the mig gene of M. avium and the DT1 gene of M. intracellulare are detected, preferably following amplification. In addition, the method distinguishes between species of M. avium and M. intracellulare. Also described are oligonucleotides that can be used as primers to amplify target genes such as mig and DT1 genes and as probes as well as kits containing the oligonucleotide.

Claims

1. A kit comprising:

a first oligonucleotide primer that is 20-100 nucleotides in length and comprises SEQ ID NO;

4 or the full complement thereof and a second oligonucleotide primer that is 21-100 nucleotides in length and comprises SEQ ID NO;

5 or the full complement thereof, that, together, constitute a primer pair capable of amplifying wherein both oligonucleotide primers hybridize to a first target nucleic acid that is the insertion sequence transposase (IS1245) of M. avium or a region thereof;

a third oligonucleotide primer that is 15-100 nucleotides in length and a fourth oligonucleotide primer that is 15-100 nucleotides in length, that, together constitute a primer pair capable of amplifying wherein both oligonucleotide primers hybridize to a second target nucleic acid that is the DT1 gene of M. intracellulare, M. avium serovar 2 and M. avium serovar 3 or a region thereof and wherein each primer is at least 75% identical to the corresponding region of the DT1 gene with which it aligns; and

a fifth oligonucleotide that is 15-70 nucleotides in length, is at least 75% identical to a corresponding region of IS1245, and hybridizes to an IS1245 amplicon produced with the first and second oligonucleotide primers, wherein the fifth oligonucleotide comprises one or more detectable labels selected from the group consisting of fluorescent dyes, 32P, 35S, 3H, 14C, 125I, 131I, electron-dense reagents, enzymes, colorimetric labels, magnetic labels, biotin, dioxigenin, haptens, proteins for which antisera or monoclonal antibodies are available, and ligands capable of forming a complex with a corresponding receptor; and

wherein the components of the kit are used to detect Mycobacterium avium complex.

2. The kit of claim 1, wherein said fifth oligonucleotide comprises SEQ ID NO:

6 or the full complement thereof.

3. The kit of claim 1, wherein the third oligonucleotide primer comprises SEQ ID NO:

7 or the full complement thereof and the fourth oligonucleotide primer comprises SEQ ID NO;

8 or the full complement thereof.

4. A kit comprising:

a first and a second primer pair, each primer pair comprising two different oligonucleotide primers that are 20-100 nucleotides in length, and at least one oligonucleotide probe that is 15-70 nucleotides in length and is at least 75% identical to a region of IS1245, wherein the first primer pair is capable of amplifying IS1245 of M. avium or a region thereof and the second primer pair is capable of amplifying the DT1 gene of M. intracellulare, M. avium serovar 2 and M. avium serovar 3 or a region thereof;

wherein the oligonucleotide probe comprises one or more detectable labels selected from the group consisting of fluorescent dyes, 32P, 35S, 3H, 14C, 125I, 131I, electron-dense reagents, enzymes, colorimetric labels, magnetic labels, biotin, dioxigenin, haptens, proteins for which antisera or monoclonal antibodies are available, and ligands capable of forming a complex with a corresponding receptor; and

wherein at least one primer pair is selected from;

(i) a primer comprising SEQ ID NO;

4 or the full complement thereof and a primer comprising SEQ ID NO;

5 or the full complement thereof, or

(ii) a primer comprising SEQ ID NO;

7 or the full complement thereof and a primer comprising SEQ ID NO;

8 or the full complement thereof.

5. The kit of claim 4, wherein the second primer pair comprises a primer comprising SEQ ID NO:

7 or the full complement thereof and a primer comprising SEQ ID NO;

8 or the full complement thereof.

6. The kit of claim 4, wherein the first primer pair comprises a primer comprising SEQ ID NO:

4 or the full complement thereof and a primer comprising SEQ ID NO;

5 or the full complement thereof.

7. The kit of claim 6, wherein the second primer pair comprises a primer comprising SEQ ID NO:

7 or the full complement thereof and a primer comprising SEQ ID NO;

8 or the full complement thereof.

8. A kit comprising:

a first oligonucleotide primer that is 20-100 nucleotides in length and comprises SEQ ID NO;

7 or the full complement thereof and a second oligonucleotide primer that is 20-100 nucleotides in length and comprises SEQ ID NO;

8 or the full complement thereof, wherein both oligonucleotide primers hybridize to a first target nucleic acid that is the DT1 gene of M. intracellulare, M. avium serovar 2 and M. avium serovar 3 or a region thereof;

a third oligonucleotide primer that is 15-100 nucleotides in length and a fourth oligonucleotide primer that is 15-100 nucleotides in length, wherein both oligonucleotide primers hybridize to a second target nucleic acid that is the insertion sequence transposase (IS1245) of M. avium or a region thereof, and wherein each oligonucleotide primer is at least 75% identical to the corresponding region of the IS1245 gene with which it aligns; and

a fifth oligonucleotide that is 15-70 nucleotides in length, is at least 75% identical to a corresponding region of DT1, and hybridizes to a DT1 amplicon produced with the first and second oligonucleotide primer, wherein the fifth oligonucleotide comprises one or more detectable labels selected from the group consisting of fluorescent dyes, 32P, 35S, 3H, 14C, 125I, 131I, electron-dense reagents, enzymes, colorimetric labels, magnetic labels, biotin, dioxigenin, haptens, proteins for which antisera or monoclonal antibodies are available, and ligands capable of forming a complex with a corresponding receptor; and

wherein the components of the kit are used to detect Mycobacterium avium complex.

9. The kit of claim 8, wherein the fifth oligonucleotide comprises SEQ ID NO:

9 or the full complement thereof.